Access cutting-edge pulmonary fibrosis treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access pulmonary fibrosis specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary fibrosis treatment provided free
Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.
Sponsor: United Therapeutics
Check if you qualify for this pulmonary fibrosis clinical trial in Phoenix, AZ
If you're searching for pulmonary fibrosis treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.